SpringWorks Therapeutics, Inc.

Bank of New York Mellon Corp

Report date

6/30/2025

Quarter

2025 Q2

Filed

8/5/2025

Shares

200,634

Value ($000)

9,428

Weight

0.0%

2019 Q4 - 2025 Q2 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q2	8/5/2025	9,428	0.0%	200,634	6/30/2025
2025 Q1	4/29/2025	8,263	0.0%	187,247	3/31/2025
2024 Q4	2/4/2025	7,079	0.0%	195,942	12/31/2024
2024 Q3	11/12/2024	7,271	0.0%	226,928	9/30/2024
2024 Q2	7/25/2024	11,262	0.0%	298,961	6/30/2024
2024 Q1	4/25/2024	11,458	0.0%	232,800	3/31/2024
2023 Q4	1/29/2024	8,801	0.0%	241,122	12/31/2023
2023 Q3	10/24/2023	5,031	0.0%	217,625	9/30/2023
2023 Q2	8/3/2023	5,776	0.0%	220,303	6/30/2023
2023 Q1	5/9/2023	3,273	0.0%	127,160	3/31/2023
2022 Q4	2/14/2023	3,275	0.0%	125,918	12/31/2022
2022 Q3	11/14/2022	4,293	0.0%	150,454	9/30/2022
2022 Q2	8/15/2022	3,145	0.0%	127,721	6/30/2022
2022 Q1	5/11/2022	6,576	0.0%	116,523	3/31/2022
2021 Q4	2/11/2022	7,260	0.0%	117,125	12/31/2021
2021 Q3	11/18/2021	7,382	0.0%	116,356	9/30/2021
2021 Q2	8/11/2021	8,983	0.0%	108,996	6/30/2021
2021 Q1	5/13/2021	6,620	0.0%	89,990	3/31/2021
2020 Q4	2/9/2021	6,679	0.0%	92,092	12/31/2020
2020 Q3	11/12/2020	3,600	0.0%	75,510	9/30/2020
2020 Q2	8/12/2020	3,149	0.0%	74,980	6/30/2020
2020 Q1	5/6/2020	1,060	0.0%	39,260	3/31/2020
2019 Q4	2/14/2020	1,004	0.0%	26,081	12/31/2019